CPAP Benefit in CVD With OSA Depends on Hypercholesterolemia, OSA Event Length
Researchers explored the cardiovascular benefit vs harm of prescribing CPAP in patients with acute coronary syndrome and nonsleepy OSA.
Researchers explored the cardiovascular benefit vs harm of prescribing CPAP in patients with acute coronary syndrome and nonsleepy OSA.
Imaging plays a central role in diagnosing and managing fibrosing lung diseases. A methodical evaluation of HRCT is critical for identifying various lung fibroses. https://bit.ly/3UfNOfO
Panthera Dental will launch the Panthera Sleep Research Grant, a funding opportunity for investigator-initiated research proposals.
Newborns with intrauterine growth restriction (IUGR) have a higher likelihood of developing pulmonary arterial hypertension (PAH) in adulthood. Although there is increasing evidence suggesting that…
American Thoracic Society
Rationale: Maternal obstructive sleep apnea–hypopnea (OSAH) is associated with hypertensive disorders of pregnancy (HDP). OSAH treatment with positive airway pressure (PAP) in the general populatio…
ADVENT program is a medical education program focused on Type 2 inflammation.
A study demonstrates a promising new method using Sunrise’s HST for titrating oral appliances in the treatment of OSA.
Rationale: Chronic obstructive pulmonary disease (COPD) due to tobacco smoking commonly presents when extensive lung damage has occurred. Objectives: We hypothesized that structural change would…
Among patients with severe asthma receiving omalizumab, breathomics and plasma lipidomics predicted early and late treatment responses, according to results published in American Journal of…
Rationale: Density thresholds in computed tomography (CT) lung scans quantify air trapping (AT) at the whole-lung level but are not informative for AT in specific…